CHINA PHARMA HOLDINGS, INC. Increase (Decrease) in Accounts Receivable
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Increase (Decrease) in Accounts Receivable of $13.88 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-01.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-04-01
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in accounts receivable for the quarter ending 2020-03-31 was $0.00.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in accounts receivable for the quarter ending 2019-12-31 was $0.00.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in accounts receivable for the quarter ending 2019-09-30 was $0.00.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in accounts receivable for the quarter ending 2019-06-30 was $0.00.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in accounts receivable for fiscal 2025 was $13.88M.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in accounts receivable for fiscal 2024 was $0.00.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in accounts receivable for fiscal 2023 was $0.00.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in accounts receivable for fiscal 2022 was $0.00.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|---|---|
| 2025-12-31 | $13.88M 10-K · filed 2026-04-01 | |||||
| 2024-12-31 | $0.00 10-K · filed 2026-04-01 | |||||
| 2023-12-31 | $0.00 10-K · filed 2025-03-31 | |||||
| 2022-12-31 | $0.00 10-K · filed 2024-04-01 | |||||
| 2021-12-31 | $0.00 10-K · filed 2023-03-30 | |||||
| 2020-12-31 | $687.72K 10-K · filed 2022-03-30 | |||||
| 2020-03-31 | $0.00 10-Q · filed 2020-05-14 | $0.00 derived: sum of 2 quarters · filed 2021-03-26 | $0.00 derived: sum of 3 quarters · filed 2021-03-26 | $0.00 derived: sum of 4 quarters · filed 2021-03-26 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | $0.00 derived: sum of 2 quarters · filed 2021-03-26 | $0.00 derived: sum of 3 quarters · filed 2021-03-26 | $0.00 10-K · filed 2021-03-26 | ||
| 2019-09-30 | $0.00 10-Q · filed 2019-11-14 | $0.00 derived: sum of 2 quarters · filed 2019-11-14 | $0.00 10-Q · filed 2019-11-14 | $0.00 derived: sum of 4 quarters · filed 2020-05-14 | ||
| 2019-06-30 | $0.00 10-Q · filed 2019-08-14 | $0.00 10-Q · filed 2019-08-14 | $0.00 derived: sum of 3 quarters · filed 2020-05-14 | $0.00 derived: sum of 4 quarters · filed 2020-05-14 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-14 | $0.00 derived: sum of 2 quarters · filed 2020-05-14 | $0.00 derived: sum of 3 quarters · filed 2020-05-14 | $0.00 derived: sum of 4 quarters · filed 2020-05-14 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $0.00 derived: sum of 2 quarters · filed 2020-03-30 | $0.00 derived: sum of 3 quarters · filed 2020-03-30 | $0.00 10-K · filed 2020-03-30 | ||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-14 | $0.00 derived: sum of 2 quarters · filed 2019-11-14 | $0.00 10-Q · filed 2019-11-14 | $0.00 derived: sum of 4 quarters · filed 2019-11-14 | ||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-14 | $0.00 10-Q · filed 2019-08-14 | $0.00 derived: sum of 3 quarters · filed 2019-08-14 | $0.00 derived: sum of 4 quarters · filed 2019-08-14 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-14 | $0.00 derived: sum of 2 quarters · filed 2019-05-14 | $0.00 derived: sum of 3 quarters · filed 2019-05-14 | $0.00 derived: sum of 4 quarters · filed 2019-05-14 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-28 | $0.00 derived: sum of 2 quarters · filed 2019-03-28 | $0.00 derived: sum of 3 quarters · filed 2019-03-28 | $0.00 10-K · filed 2019-03-28 | ||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-14 | $0.00 derived: sum of 2 quarters · filed 2018-11-14 | $0.00 10-Q · filed 2018-11-14 | $13.50M derived: sum of 4 quarters · filed 2018-11-14 | ||
| 2017-06-30 | $0.00 10-Q · filed 2018-08-14 | $0.00 10-Q · filed 2018-08-14 | $13.50M derived: sum of 3 quarters · filed 2018-08-14 | |||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-14 | $13.50M derived: sum of 2 quarters · filed 2018-05-14 | ||||
| 2016-12-31 | $13.50M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $13.50M 10-K · filed 2018-04-02 | ||||
| 2016-09-30 | $0.00 10-Q · filed 2017-11-14 | |||||
| 2014-09-30 | $369.11K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$2.84M derived: sum of 2 quarters · filed 2014-11-14 | -$3.03M 10-Q · filed 2014-11-14 | |||
| 2014-06-30 | -$3.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$3.40M 10-Q · filed 2014-08-14 | ||||
| 2014-03-31 | -$185.26K 10-Q · filed 2014-05-15 | |||||
| 2013-09-30 | -$595.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$1.64M derived: sum of 2 quarters · filed 2014-11-14 | $1.08M 10-Q · filed 2014-11-14 | |||
| 2013-06-30 | -$1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $1.67M 10-Q · filed 2014-08-14 | ||||
| 2013-03-31 | $2.71M 10-Q · filed 2014-05-15 | $589.19K 10-Q · filed 2013-05-14 | ||||
| 2012-09-30 | $1.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $1.70M derived: sum of 2 quarters · filed 2013-11-14 | -$2.44M 10-Q · filed 2013-11-14 | -$4.14M derived: sum of 4 quarters · filed 2013-11-14 | ||
| 2012-06-30 | $384.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$3.76M 10-Q · filed 2013-08-14 | -$5.46M derived: sum of 3 quarters · filed 2013-08-14 | -$12.41M derived: sum of 4 quarters · filed 2013-08-14 | ||
| 2012-03-31 | -$4.14M 10-Q · filed 2013-05-14 | -$5.15M 10-Q · filed 2012-05-14 | -$5.84M derived: sum of 2 quarters · filed 2013-05-14 | -$12.79M derived: sum of 3 quarters · filed 2013-05-14 | -$14.07M derived: sum of 4 quarters · filed 2013-05-14 | |
| 2011-12-31 | -$1.70M derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-14 | -$8.65M derived: sum of 2 quarters · filed 2012-03-14 | -$9.93M derived: sum of 3 quarters · filed 2012-03-14 | -$11.39M 10-K · filed 2012-03-14 | ||
| 2011-09-30 | -$6.95M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-03-06 | -$8.23M derived: sum of 2 quarters · filed 2012-03-06 | -$9.69M 10-Q/A · filed 2012-03-06 | -$4.53M 10-Q · filed 2011-11-10 | -$14.53M derived: sum of 4 quarters · filed 2012-05-14 | |
| 2011-06-30 | -$1.28M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2011-09-06 | -$2.74M 10-Q/A · filed 2011-09-06 | -$7.58M derived: sum of 3 quarters · filed 2012-05-14 | -$8.57M derived: sum of 4 quarters · filed 2012-05-14 | ||
| 2011-03-31 | -$1.46M 10-Q · filed 2012-05-14 | -$6.30M derived: sum of 2 quarters · filed 2012-05-14 | -$7.29M derived: sum of 3 quarters · filed 2012-05-14 | |||
| 2010-12-31 | -$4.84M derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-14 | -$5.83M derived: sum of 2 quarters · filed 2012-03-14 | -$9.23M 10-K · filed 2012-03-14 | |||
| 2010-09-30 | -$992.24K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-03-06 | -$4.39M 10-Q/A · filed 2012-03-06 | ||||
| 2010-06-30 | -$3.40M 10-Q/A · filed 2011-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |